Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Treasury Shares: 2022-2025

Historic Treasury Shares for Gossamer Bio (GOSS) over the last 2 years, with Sep 2025 value amounting to $2.7 million.

  • Gossamer Bio's Treasury Shares was N/A to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year change of. This contributed to the annual value of $427,698 for FY2023, which is 68.32% down from last year.
  • Per Gossamer Bio's latest filing, its Treasury Shares stood at $2.7 million for Q3 2025, which was up 30,809.68% from $8,606 recorded in Q1 2024.
  • Over the past 5 years, Gossamer Bio's Treasury Shares peaked at $2.7 million during Q3 2025, and registered a low of $8,606 during Q1 2024.
  • Over the past 3 years, Gossamer Bio's median Treasury Shares value was $438,109 (recorded in 2023), while the average stood at $752,824.
  • Data for Gossamer Bio's Treasury Shares shows a maximum YoY slumped of 98.42% (in 2024) over the last 5 years.
  • Over the past 4 years, Gossamer Bio's Treasury Shares (Quarterly) stood at $1.4 million in 2022, then plummeted by 68.32% to $427,698 in 2023, then tumbled by 98.42% to $8,606 in 2024, then reached $2.7 million in 2025.
  • Its last three reported values are $2.7 million in Q3 2025, $8,606 for Q1 2024, and $427,698 during Q4 2023.